1.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-96-C-0113F, NCI-MB-386, NCI-T96-0029N, T96-0029, NCT00019188
|
|
2.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000065424, UCCRC-9018, UCCRC-8381, NCI-G97-1162, NCT00002952
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UPCC-10401, NCI-1831, 1831, NCT00052377
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-97002, ROCHE-BO15469, NCI-G97-1236
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-97-C-0118, NCI-T97-0009, T97-0009
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-E1E96, E1E96, NCT00003017
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-1A96, NCT00003149, E1A96
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-170B
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-97073, NCI-T97-0050, NCT00003210, T97-0050
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: LAC-USC-10M973, NCI-G98-1432, NCI-T97-0099, NCT00003339, T97-0099
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: AMC-008, NCT00003575
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-01-C-0067, NCI-4010, 4010, NCT00020449
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000068578, UCCRC-9845, NCI-1192, NCT00015977
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-ID-00232, NCI-2251, NCT00016289, 2251
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068990, U10CA031946, CALGB-500001, NCT00026143
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N0087, NCT00026182, N0087
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: LAC-USC-10M011, LAC-USC-IRB-013030, NCI-5506, NCT00031733, 5506
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-11447A, NCI-1330, NCT00064168, 1330
|
|
19.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: PCI-9432, DFCI-94044, NCI-V94-0495
|
|
20.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95008, NCI-V95-0662
|
|
21.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-95-C-0143B, NCI-T95-0039N, T95-0039
|
|
22.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ID97-027, P30CA016672, MDA-ID-97027, NCI-T97-0034, CDR0000065681, T97-0034, NCT00003046
|
|
23.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BIH-97-1083, NCI-T97-0053, NCT00003330, T97-0053
|
|
24.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: NCI
Protocol IDs: BIH-L97-0252, NCI-T98-0002, NCT00003412, T98-0002
|
|
25.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: PCI-98-031, PCI-MWH-97-039, NCI-T97-0031, NCT00003439, T97-0031
|
Mobile | Español
